Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report Intel FAQ API Sign In →
52 /100
HIGH RISK
Score updated Jul 28, 2026

ALMR — Alamar Biosciences, Inc. Dilution Risk Tracker

Track ALMR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ALMR — Get alerts when the score changes →

As of July 28, 2026, Alamar Biosciences, Inc. (ALMR) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. Alamar Biosciences, Inc. has a market capitalization of $1.42B, 69.31M shares outstanding.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
40
⚠️ Warrant Exposure
40
🔄Convertible Debt

Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ALMR.
🔔 Track ALMR — Get forecast alerts →

Market Data

Market Cap$1.42B
Shares Outstanding69.31M
Float38.15M
Cash$64.59M
Debt$105.55M
Short InterestN/A

Institutional Holdings

28.3% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track ALMR for full holder detail →

Short Interest

Short Interest2.25M
Days to Cover7.6
% of Float5.9%
FINRA data as of Jul 15, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-31
xbrl XBRL WARRANT 2026-03-31
Full SEC filing analysis available with free account

Recent News

No recent news

What This Means for ALMR Shareholders

Alamar Biosciences, Inc. (ALMR) has a DilutionScore of 52/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 28, 2026, updated from SEC EDGAR data.

DilutionWatch's EDGAR monitoring for ALMR shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for ALMR in real-time, scanning EDGAR every 60 seconds. The DilutionWatch shows real-time score changes for ALMR alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding ALMR's Dilution Risk Factors

Primary Risk Drivers

The most significant dilution risks for Alamar Biosciences stem from its Offering Ability and Cash Runway scores. Offering Ability is at a concerning level, indicating the company has the capacity to raise capital through new equity offerings, which directly increases the share count. The Cash Runway score of 25 signals that the company’s cash reserves are limited, creating pressure to seek additional funding. Together, these factors suggest a high probability of future dilution as the company may need to issue new shares to fund operations or growth.

Factors Currently Not a Concern

While several risk indicators are elevated, Convertible Note Risk is currently low, suggesting that the company’s convertible debt obligations pose minimal threat at this time. Float Risk and Warrant Exposure are also at moderate levels, indicating existing instruments that could dilute shares but are not immediately problematic. A change in either of these areas—such as an increase in outstanding warrants or a significant rise in convertible note balances—could elevate their risk scores. Additionally, if the company were to announce a new equity offering, Offering Ability would spike accordingly.

SEC Filings to Watch

Several filings provide insight into ALMR’s potential dilution activity. An S-3 registration statement signals intent to raise capital through a shelf offering, which could lead to substantial share issuance. A 424B5 filing indicates a planned offering of securities, often tied to new funding rounds. An 8-K Item 1.01 filing would report material events such as new equity issuances or significant agreements that may increase share count. A 10-Q filing might reveal updated financials and management discussions indicating increased reliance on capital markets, potentially signaling future dilution.

How Dilution Happens

Dilution occurs when the company issues new shares to raise capital. With a high Offering Ability, ALMR could initiate equity offerings that increase the total number of outstanding shares. If the company is operating with limited cash reserves, as indicated by its Cash Runway score, it may be forced to issue more shares to fund operations or strategic initiatives. Existing shareholders see their ownership percentage decrease with each new issuance, diluting their stake in the company. This process typically involves regulatory filings and shareholder approvals, but once initiated, the impact on share count is immediate and permanent.

What Would Make This Worse

A worsening risk profile could occur if ALMR were to announce a large-scale equity offering or enter into convertible debt agreements that convert into shares at low prices. If the company’s cash runway deteriorates further, it may be forced to issue more shares in short order, increasing dilution pressure. Additionally, a spike in warrant activity or an increase in convertible note balances could compound the risk. Any of these events would elevate existing scores and signal growing financial strain, making the company’s capital structure increasingly vulnerable.

Key Insight

The interplay between funding needs and share issuance creates a dynamic dilution environment where low cash reserves amplify the risk of future equity dilution.

How to Monitor ALMR for Dilution Risk

What This Risk Level Means

For a small-cap operating company like Alamar Biosciences, a high dilution risk score indicates that the firm is likely relying heavily on equity financing to fund operations. In such companies, dilution risk is particularly concerning because of limited access to capital markets and a higher dependency on issuing new shares. A score in this range suggests the company may be at risk of significant share dilution through various mechanisms like offerings, warrants, or ATM programs, which could reduce shareholder value and increase financial uncertainty.

What Typically Happens Next

Companies with elevated dilution exposure often proceed with capital-raising activities such as shelf registrations or ATM programs. These vehicles allow firms to issue equity on demand, which can lead to rapid share issuance and dilution. Warrant exercises are another common occurrence, especially when companies have issued warrants as part of financing deals. The timing of these events is often unpredictable but tends to align with strategic milestones or financial needs. Monitoring Shelf & ATM Monitor can help identify upcoming filings and issuance patterns.

Monitoring Playbook

To track ALMR’s dilution risk, use DilutionWatch to regularly check score changes and factor updates. Set alerts for any increase in Offering Ability or Float Risk scores above 50/100. Review quarterly SEC filings closely for new equity offerings, warrant issuances, or ATM program announcements. Check the company’s website and investor relations materials for updates on capital structure changes. A weekly check of DilutionWatch is recommended, with more frequent monitoring during earnings seasons or when new filings are announced.

Early Warning Signals

Several signals indicate a worsening dilution profile. First, an increase in Offering Ability score above 65/100 may suggest an imminent equity offering. Second, any new warrant issuance or exercise activity in SEC filings could raise Float Risk significantly. Third, the filing of a shelf registration statement often indicates a company is preparing to issue shares at will, which can dramatically impact existing shareholders.

What a Positive Resolution Looks Like

A positive shift in ALMR’s dilution profile would be a capital raise that improves cash runway or a reduction in warrant exposure through expiry or conversion. A decrease in Offering Ability score below 50/100, or a significant drop in Float Risk due to reduced outstanding warrants, would also indicate improved conditions. Additionally, a paydown of debt or a strategic partnership that reduces the need for future equity issuance can help stabilize the company’s capital structure.

Watch For

Any sudden spike in Offering Ability score or appearance of new warrant grants in SEC filings, as these are strong indicators of increased dilution risk.

Full SEC filing analysis available with free account  →
Track ALMR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ALMR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ALMR
ALMR Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.